Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathwayVasanthi S. Viswanathan, Stuart L. Schreiber, Matthew J. Ryan et al.|Nature|2017Cited by 2k
Modelling vemurafenib resistance in melanoma reveals a strategy to forestall drug resistanceMeghna Das Thakur, Darrin D. Stuart, Fernando Salangsang et al.|Nature|2013Cited by 735
Predictors of responses to immune checkpoint blockade in advanced melanomaNicolas Jacquelot, Laurence Zitvogel, María P. Roberti et al.|Nature Communications|2017Cited by 201
Evolutionary predictability of genetic versus nongenetic resistance to anticancer drugs in melanomaOskar Marín-Béjar, Jean‐Christophe Marine, Aljosja Rogiers et al.|Cancer Cell|2021Cited by 154
Genetic and Environmental Determinants of Immune Response to Cutaneous MelanomaJoanna Poźniak, Julia Newton‐Bishop, Jérémie Nsengimana et al.|Cancer Research|2019Cited by 53